![Philippe Wiesel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philippe Wiesel
Directeur Technique/Scientifique/R&D chez
AGOMAB THERAPEUTICS NV
Fortune : - $ au 30/06/2026
Profil
Philippe Wiesel is the founder of Genexion SA. Currently, Dr. Wiesel is Chief Medical Officer & Executive Vice President at Calliditas Therapeutics Suisse SA since 2010 and Chief Medical Officer at AgomAb Therapeutics NV since 2021.
Formerly, Dr. Wiesel was Medical Director at EMD Serono, Inc., Serono SA, and Serono International SA, and Clinical Development Advisor at Funxional Therapeutics Ltd. Dr. Wiesel earned a doctorate from the University of Lausanne in 1993.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/03/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Philippe Wiesel
| Sociétés | Poste | Début |
|---|---|---|
| AGOMAB THERAPEUTICS NV | Directeur Technique/Scientifique/R&D | 01/01/2021 |
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Directeur Technique/Scientifique/R&D | 26/05/2011 |
Anciens postes connus de Philippe Wiesel
| Sociétés | Poste | Fin |
|---|---|---|
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Directeur Technique/Scientifique/R&D | - |
Serono International SA | Directeur Technique/Scientifique/R&D | - |
Genexion SA | Fondateur | - |
Serono SA
 Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs | Directeur Technique/Scientifique/R&D | - |
Funxional Therapeutics Ltd.
 Funxional Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides drug and therapeutical development services | Corporate Officer/Principal | - |
Formation de Philippe Wiesel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
34
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Health Technology |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
University of Lausanne
 University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Funxional Therapeutics Ltd.
Funxional Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides drug and therapeutical development services | Health Technology |
Serono International SA | |
Genexion SA | |
AgomAb Therapeutics NV
 AgomAb Therapeutics NV BiotechnologyHealth Technology Develops molecular therapies for regeneration of damaged tissues | Health Technology |
